altona Diagnostics: strengthening transplant diagnostic confidence with IVDR compliance and the AltoStar® Analysis software
altona Diagnostics has announced that the CE-IVD marking under Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) for all AltoStar® PCR kits intended for monitoring of transplant patients will be completed during spring 2026. This milestone illustrates altona Diagnostics’ long-term commitment to regulatory excellence and clinical reliability.